DE2527291A1 - Acylderivate - Google Patents

Acylderivate

Info

Publication number
DE2527291A1
DE2527291A1 DE19752527291 DE2527291A DE2527291A1 DE 2527291 A1 DE2527291 A1 DE 2527291A1 DE 19752527291 DE19752527291 DE 19752527291 DE 2527291 A DE2527291 A DE 2527291A DE 2527291 A1 DE2527291 A1 DE 2527291A1
Authority
DE
Germany
Prior art keywords
dioxo
tetrahydro
methyl
formula
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19752527291
Other languages
German (de)
English (en)
Other versions
DE2527291C2 (ja
Inventor
Marc Dr Montavon
Roland Dr Reiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2527291A1 publication Critical patent/DE2527291A1/de
Application granted granted Critical
Publication of DE2527291C2 publication Critical patent/DE2527291C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752527291 1974-06-21 1975-06-19 Acylderivate Granted DE2527291A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (2)

Publication Number Publication Date
DE2527291A1 true DE2527291A1 (de) 1976-01-08
DE2527291C2 DE2527291C2 (ja) 1988-01-14

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752527291 Granted DE2527291A1 (de) 1974-06-21 1975-06-19 Acylderivate

Country Status (25)

Country Link
JP (1) JPS625917B2 (ja)
AT (1) AT337897B (ja)
AU (1) AU498387B2 (ja)
BE (1) BE830455A (ja)
BR (1) BR7503782A (ja)
CA (1) CA1111021A (ja)
CH (1) CH609989A5 (ja)
CU (1) CU34293A (ja)
DD (1) DD121113A5 (ja)
DE (1) DE2527291A1 (ja)
DK (2) DK153155C (ja)
FI (1) FI751815A (ja)
FR (1) FR2275215A1 (ja)
GB (1) GB1471804A (ja)
HU (1) HU170576B (ja)
IE (1) IE41888B1 (ja)
IL (1) IL47299A (ja)
LU (1) LU72771A1 (ja)
NL (1) NL180665C (ja)
NO (1) NO752202L (ja)
NZ (1) NZ177508A (ja)
PH (1) PH13030A (ja)
SE (1) SE431755B (ja)
SU (2) SU635873A3 (ja)
ZA (1) ZA753086B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831092A1 (de) * 1977-07-14 1979-02-01 Shionogi & Co Dihydrotriazinylthiomethyloxacephalosporine und ihre salze sowie verfahren zu ihrer herstellung
WO2002086143A2 (en) * 2001-04-19 2002-10-31 Bioferma Murcia, S.A. Enzymatic process for preparing cephalosporin derivatives

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7805715A (nl) * 1977-06-03 1978-12-05 Hoffmann La Roche Werkwijze voor het bereiden van acylderivaten.
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
DK2250156T3 (en) 2008-03-05 2015-08-03 Merck Patent Gmbh Pyrazinonderivater as insulinsekretionsstimulatorer, methods of procurement of them and use thereof for the treatment of diabetes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2356704A1 (de) * 1972-11-14 1974-05-22 Smithkline Corp 3-(heterocyclische-thiomethyl)-cephalosporinverbindungen und ihre pharmakologisch vertraeglichen salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2356704A1 (de) * 1972-11-14 1974-05-22 Smithkline Corp 3-(heterocyclische-thiomethyl)-cephalosporinverbindungen und ihre pharmakologisch vertraeglichen salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Demain and Solomon: Antibiotics Containing Beta-Lactam Structure, Springer-Verlag, 1983, Bd.II, S. 433, 435 *
Flynn, Cephalosporins and Penicillins, Academic Press 1972, S. 507-514, 560-561, 572,579 *
J.Antibiotics 28 (1975) S. 463-470 *
J.Antibiotics 32 (1979) S. 728 *
J.Med.Chem.17 (1974) 34-41 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2831092A1 (de) * 1977-07-14 1979-02-01 Shionogi & Co Dihydrotriazinylthiomethyloxacephalosporine und ihre salze sowie verfahren zu ihrer herstellung
WO2002086143A2 (en) * 2001-04-19 2002-10-31 Bioferma Murcia, S.A. Enzymatic process for preparing cephalosporin derivatives
WO2002086143A3 (en) * 2001-04-19 2003-01-09 Bioferma Murcia S A Enzymatic process for preparing cephalosporin derivatives

Also Published As

Publication number Publication date
IE41888L (en) 1975-12-21
SU589921A3 (ru) 1978-01-25
HU170576B (ja) 1977-07-28
DK155329B (da) 1989-03-28
NL7507390A (nl) 1975-12-23
NL180665C (nl) 1987-04-01
CU34293A (es) 1979-01-16
FR2275215A1 (fr) 1976-01-16
JPS5113793A (ja) 1976-02-03
NL180665B (nl) 1986-11-03
SE431755B (sv) 1984-02-27
PH13030A (en) 1979-11-15
DK155329C (da) 1989-08-07
DK271975A (da) 1975-12-22
GB1471804A (en) 1977-04-27
BE830455A (fr) 1975-12-22
AU498387B2 (en) 1979-03-08
BR7503782A (pt) 1976-07-06
IE41888B1 (en) 1980-04-23
AT337897B (de) 1977-07-25
DD121113A5 (ja) 1976-07-12
NZ177508A (en) 1978-04-03
ATA476975A (de) 1976-11-15
SU635873A3 (ru) 1978-11-30
FI751815A (ja) 1975-12-22
CA1111021A (en) 1981-10-20
IL47299A0 (en) 1976-10-31
IL47299A (en) 1979-01-31
FR2275215B1 (ja) 1980-05-16
LU72771A1 (ja) 1977-03-04
SE7506908L (sv) 1975-12-22
DK453687A (da) 1987-08-28
DE2527291C2 (ja) 1988-01-14
DK453687D0 (da) 1987-08-28
DK153155C (da) 1988-10-31
AU8191275A (en) 1976-12-09
ZA753086B (en) 1976-04-28
NO752202L (ja) 1975-12-23
DK153155B (da) 1988-06-20
JPS625917B2 (ja) 1987-02-07
CH609989A5 (en) 1979-03-30

Similar Documents

Publication Publication Date Title
EP0034760B1 (de) Cephalosporinderivate, sie enthaltende pharmazeutische Präparate und Verfahren zu ihrer Herstellung
CH652129A5 (de) Neue cephalosporine, verfahren zur herstellung derselben.
CH637396A5 (de) Thiadiazolyl-cephalosporin-analoge.
CH639666A5 (de) Cephalosporansaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung.
Doyle et al. 272. Derivatives of 6-aminopenicillanic acid. Part I. α-Aminobenzylpenicillin and some related compounds
DE2736471A1 (de) Ungesaettigte 7-acylamido-3-cephem- 4-carbonsaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel und veterinaermittel
DE2527291A1 (de) Acylderivate
DE2225694A1 (de) Cephalosporinverbindungen und Ver fahren zu deren Herstellung
DE3686749T2 (de) Cephalosporinverbindungen und sie enthaltende bakterizide.
CH636879A5 (de) Verfahren zur herstellung 7-substituierter aminoacetamido-oxadethia-cephalosporine.
DE2056983B2 (de) S-Heterocyclylthiomethyl-Cephalosporine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4091211A (en) Cephalosporins
DE2521063A1 (de) Phenylacetamidocephalosporin- derivate
DE2234280A1 (de) Cephalosporinverbindungen und verfahren zu deren herstellung
DE2700271A1 (de) Thienopyridinderivate
US4348518A (en) Cephalosporins
EP0026811A1 (en) Cephalosporin derivatives
EP0075104A2 (de) Cephalosporinderivate, Verfahren zu deren Herstellung und Zwischenprodukte dafür sowie entsprechende pharmazeutische Präparate
DE2336344A1 (de) Penicillin- und cephalosporin-rsulfoxide, ihre salze und ester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
KR790001023B1 (ko) 아실 유도체의 제조방법
DE2600880A1 (de) Neue cephalosporine, verfahren zur herstellung derselben und mittel mit einem gehalt derselben
DE2559932C2 (de) Cephalosporine, Verfahren zur Herstellung derselben und Mittel mit einem Gehalt derselben
DE2150516C3 (de) 7-[ α -Amino-1'-cyclohexenyl-acetamido]-cephalosporansäuren und Verfahren zu ihrer Herstellung
DE2655717A1 (de) Thiadiazolylderivate von 7-acylamido-3-cephem-4-carbonsaeure, verfahren zu deren herstellung und dieselben enthaltende pharmazeutische und veterinaermedizinische mittel
DD201142A5 (de) Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
Q176 The application caused the suspense of an application

Ref document number: 2534071

Country of ref document: DE

D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: F. HOFFMANN-LA ROCHE AG, BASEL, CH

8328 Change in the person/name/address of the agent

Free format text: LEDERER, F., DIPL.-CHEM. DR., 8000 MUENCHEN RIEDERER FRHR. VON PAAR ZU SCHOENAU, A., DIPL.-ING., PAT.-ANWAELTE, 8300 LANDSHUT